Mangoceuticals, Inc. (MGRX) Stock Statistics & Valuation Metrics

Mangoceuticals, Inc. has a market cap or net worth of $16.61M. The enterprise value is ―.

Mangoceuticals, Inc. has 11,034,023 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mangoceuticals, Inc.’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -56.30%.

The current PE Ratio of Mangoceuticals, Inc. is -0.55. Mangoceuticals, Inc.’s PEG ratio is -0.03.

In the last 12 months, Mangoceuticals, Inc. had revenue of 473.26K and earned -8.71M in profits. Earnings per share was -4.40.

In the last 12 months, operating cash flow was -4.86M and capital expenditures 0.00, giving a free cash flow of -4.86M billion.

Mangoceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Mangoceuticals, Inc. upcoming earnings date is ―, TBA Not Confirmed.

Mangoceuticals, Inc. as a current ratio of 0.05, with Debt / Equity ratio of 1.54%

In the past 12 months, Mangoceuticals, Inc. has paid 0.00 in taxes.

Mangoceuticals, Inc. EV to EBITDA ratio is -0.62, with an EV/FCF ratio of -1.02.

Mangoceuticals, Inc. has $58.65K in cash and marketable securities with $214.96K in debt, giving a net cash position of $156.31K billion.

Gross margin is 61.70%, with operating margin of -1684.48%, and net profit margin of -1839.61%.

The average price target for Mangoceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―